Figure 2.

In vivo observations of corneal edema, opacity and neovascularization in mice that received topically applied BAC eye drops. (A) Photographs of corneas from C57BL/6 and BALB/mice that were treated with various levels of BAC eye drops for 7 and 14 days. The changes in the corneas were evaluated by scoring: the corneal opacity (B); and neovascularization (C) following the methods described in the literature (Materials and Methods, n = 10). *: p < 0.05; **: p < 0.01; *, **: C57BL/6 vs. BALB/c. NC: The group received a topical administration of normal saline (NS) as the control.